SPIO-labeled yttrium microspheres for MR imaging quantification of transcatheter intrahepatic delivery in a rodent model

Radiology

Volumn 278, Issue 2, 2016, Pages 405-412

  Li, Weiguo ^a   Zhang, Zhuoli ^a   Gordon, Andrew C ^a   Chen, Jeane ^a   Nicolai, Jodi ^a   Lewandowski, Robert J ^a   Omary, Reed A ^b   Larson, Andrew C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; RADIOPHARMACEUTICAL AGENT; SUPERPARAMAGNETIC IRON OXIDE Y 90; UNCLASSIFIED DRUG; CONTRAST MEDIUM; DEXTRAN; MAGNETITE NANOPARTICLE; MICROSPHERE; SUPERPARAMAGNETIC IRON OXIDE; YTTRIUM;

ADULT; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATHETER; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG DISTRIBUTION; IMAGING PHANTOM; IN VIVO STUDY; INTRAHEPATIC DRUG ADMINISTRATION; LIMIT OF QUANTITATION; LIVER; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RAT; ANIMAL; ANIMAL MODEL; IMAGE PROCESSING; METABOLISM; PROCEDURES; RESPIRATORY GATED IMAGING; SPRAGUE DAWLEY RAT;

ANIMALS; CONTRAST MEDIA; DEXTRANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MICROSPHERES; MODELS, ANIMAL; PHANTOMS, IMAGING; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY-GATED IMAGING TECHNIQUES; YTTRIUM;

EID: 84955573958     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2015150315     Document Type: Article

References (16)

1. El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011;365(12):1118-1127.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61(2):69-90.
3. Salem R, Thurston KG, Carr BI, Goin JE, Geschwind JF. Yttrium-90 microspheres: radiation therapy for unresectable liver cancer. J Vasc Interv Radiol 2002;13(9 Pt 2):S223-S229.
4. Campbell AM, Bailey IH, Burton MA. Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol 2000;45(4):1023-1033.
5. Salem R, Thurston KG. Radioembolization with 90yttrium microspheres: A state-of-theart brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics. J Vasc Interv Radiol 2006; 17(9):1425-1439.
6. Mansberg R, Sorensen N, Mansberg V, Van der Wall H. Yttrium 90 Bremsstrahlung SPECT/CT scan demonstrating areas of tracer/tumour uptake. Eur J Nucl Med Mol Imaging 2007;34(11):1887.
7. Tehranipour N, Al-Nahhas A, Canelo R, et al. Concordant F-18 FDG PET and Y-90 Bremsstrahlung scans depict selective delivery of Y-90-microspheres to liver tumors: confirmation with histopathology. Clin Nucl Med 2007;32(5):371-374.
8. Ho S, Lau WY, Leung TW, et al. Tumour-tonormal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin. Br J Radiol 1997; 70(836):823-828.
9. Hung JC, Redfern MG, Mahoney DW, Thorson LM, Wiseman GA. Evaluation of macroaggregated albumin particle sizes for use in pulmonary shunt patient studies. J Am Pharm Assoc (Wash) 2000;40(1):46-51.
10. Gates VL, Esmail AA, Marshall K, Spies S, Salem R. Internal pair production of 90Y permits hepatic localization of microspheres using routine PET: proof of concept. J Nucl Med 2011;52(1):72-76.
11. Kao YH, Tan EH, Ng CE, Goh SW. Yttrium-90 time-of-flight PET/CT is superior to Bremsstrahlung SPECT/CT for postradioembolization imaging of microsphere biodistribution. Clin Nucl Med 2011;36(12):e186-e187.
12. Lhommel R, Goffette P, Van den Eynde M, et al. Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT. Eur J Nucl Med Mol Imaging 2009; 36(10):1696.
13. Gupta T, Virmani S, Neidt TM, et al. MR tracking of iron-labeled glass radioembolization microspheres during transcatheter delivery to rabbit VX2 liver tumors: feasibility study. Radiology 2008;249(3):845-854.
14. Gray BN, Anderson JE, Burton MA, et al. Regression of liver metastases following treatment with yttrium-90 microspheres. Aust N Z J Surg 1992;62(2):105-110.
15. Farahani K, Sinha U, Sinha S, Chiu LC, Lufkin RB. Effect of field strength on susceptibility artifacts in magnetic resonance imaging. Comput Med Imaging Graph 1990; 14(6):409-413.
16. Seppenwoolde JH, Nijsen JF, Bartels LW, Zielhuis SW, van Het Schip AD, Bakker CJ. Internal radiation therapy of liver tumors: qualitative and quantitative magnetic resonance imaging of the biodistribution of holmium-loaded microspheres in animal models. Magn Reson Med 2005;53(1):76-84.